Skip to main content
. Author manuscript; available in PMC: 2016 Feb 8.
Published in final edited form as: Peptides. 2013 Dec 25;52:104–112. doi: 10.1016/j.peptides.2013.12.010

Fig. 4.

Fig. 4

Impact of GHRH agonists on myocardial infarct burden (MI%). Bar graphs showing percentage of infarct size. Note that MI% was significantly attenuated in the groups treated with JI-38, MR-356 and MR-409. All values are shown as mean ± SEM (*p < 0.05 vs. Placebo, n = 6–12).